A detailed history of Axs Investments LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Axs Investments LLC holds 7,240 shares of ABBV stock, worth $1.27 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
7,240
Previous 8,119 10.83%
Holding current value
$1.27 Million
Previous $1.39 Million 2.66%
% of portfolio
0.4%
Previous 0.4%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $144,015 - $175,211
-879 Reduced 10.83%
7,240 $1.43 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $171,197 - $199,920
1,106 Added 15.77%
8,119 $1.39 Million
Q1 2024

Aug 16, 2024

SELL
$159.82 - $182.1 $55,137 - $62,824
-345 Reduced 4.25%
7,774 $1.42 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $402,266 - $458,345
-2,517 Reduced 26.41%
7,013 $1.28 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $42,243 - $47,575
307 Added 3.33%
9,530 $1.48 Million
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $1.08 Million - $1.25 Million
8,115 Added 732.4%
9,223 $1.37 Million
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $30,477 - $37,927
-230 Reduced 17.19%
1,108 $149,000
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $31,380 - $36,139
217 Added 19.36%
1,338 $213,000
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $155,045 - $185,940
1,121 New
1,121 $181,000
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $81,883 - $104,101
-595 Reduced 24.71%
1,813 $278,000
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $214,731 - $266,421
-1,627 Reduced 40.32%
2,408 $390,000
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $433,480 - $548,477
4,035 New
4,035 $546,000
Q3 2021

Nov 05, 2021

SELL
$106.4 - $120.78 $492,419 - $558,969
-4,628 Closed
0 $0
Q2 2021

Jul 28, 2021

BUY
$105.21 - $117.21 $117,835 - $131,275
1,120 Added 31.93%
4,628 $521,000
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $358,868 - $395,070
3,508 New
3,508 $380,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $311B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Axs Investments LLC Portfolio

Follow Axs Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axs Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axs Investments LLC with notifications on news.